MIF functional polymorphisms are associated with acute GVHD progression and steroid-refractoriness

IntroductionApproximately 50% of allogeneic hematopoietic stem cell transplantation (HSCT) Q6 recipients develop graft versus host disease (GVHD). Glucocorticoids (GC) are the first line of treatment for both acute and chronic GVHD. Failure to respond to GC [steroid-refractory (SR)] encompasses a ve...

Description complète

Détails bibliographiques

Auteurs principaux:	Aviran Aharon, Batia Avni, Daniel Louzoun, Shlomo Elias, Polina Stepensky, Ron Ram, Tsila Zuckerman, Roberto Meza-Romero, Arthur A. Vandenbark, Sigal Grisariu, Gil Benedek
Format:	Artigo
Langue:	Inglês
Publié:	Frontiers Media S.A. 2025-04-01
Collection:	Frontiers in Immunology
Sujets:	MIF acute GVHD steroid-refractory HSCT polymorphism
Accès en ligne:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1504976/full
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!